Dr. Marcellus R. Cephas

A native of Athens, Greece, Professor Lyketsos graduated from Northwestern University with a BA in Psychology and from Washington University Medical School in St. Louis with a Medical Doctorate. He completed residency and Chief Residency in psychiatry at Johns Hopkins, as well as a fellowship in clinical epidemiology. An active clinician, teacher, and researcher, Dr. Lyketsos is a world expert in the care and treatment of patients with Alzheimer’s and related dementias (ADRD). He carried out pioneering work on the epidemiology and treatment of neuropsychiatric features of AD. His team is developing biomarkers to accelerate treatment development for AD while designing and implementing innovative clinical trials. He leads efforts to ensure the provision of state-of-the-art Dementia Care for people with dementia in the community. Dr. Lyketsos is the Elizabeth Plank Althouse Professor at Johns Hopkins University. He directs the Johns Hopkins Bayview Department of Psychiatry and Behavioral Sciences, as well as the Richman Family Precision Medicine Center of Excellence in Alzheimer’s Disease and the Memory and Alzheimer’s Treatment Center. He is the recipient of multiple awards including the 2022 Argo Award for Science from the President of the Hellenic Republic. He has authored/co-authored over 450 peer-reviewed articles, chapters, commentaries, as well as five books. His work has been cited over 76,000 times with an h-index of 149. A 2021 Stanford University publication reported that he ranked #13 out of 9,246 scientists worldwide (all-time) in the field of Geriatrics. Castle-Connolly has named Dr. Lyketsos as one of America’s Top Doctors every year since 2001. A listing of Dr. Lyketsos’ publications can be found at: https://www.ncbi.nlm.nih.gov/myncbi/constantine.lyketsos.1/bibliography/public/. Dr. Lyketsos is rated as a Distinguished provider by MediFind in the treatment of Alzheimer's Disease. His top areas of expertise are Dementia, Alzheimer's Disease, Lewy Body Dementia (LBD), Cerebellar Degeneration, and Deep Brain Stimulation.

Milap Nowrangi, M.D., MS, is an assistant professor of psychiatry and behavioral sciences at The Johns Hopkins University School of Medicine. Dr. Nowrangi specializes in the diagnosis and treatment of age-related cognitive disorders, including Alzheimer's Disease and related dementias. He also is interested in the treatment or management of behavioral and cognitive sequelae of neurological diseases, including those caused by traumatic brain injury, stroke, epilepsy or toxic exposures. Dr. Nowrangi is rated as a Distinguished provider by MediFind in the treatment of Alzheimer's Disease. His top areas of expertise are Alzheimer's Disease, Dementia, Bipolar Disorder (BPD), and Neuronal Intranuclear Inclusion Disease (NIID).

Haroon Burhanullah, MD is an Assistant Professor at the Johns Hopkins University. He received fellowship training from Johns Hopkins University. He works at the Memory and Alzheimer’s Treatment Center and oversees the operations of novel disease-modifying treatment, Anti amyloid therapies like Lecanemab in Alzheimer’s disease. He is also Director of Consultation Liaison service in the ED. He is currently serving as a steering committee member of the Perioperative and Cognition PIA of Alzheimer’s Association. Dr. Burhanullah is recipient of the National Institute of Aging award on the use of artificial intelligence in the management of delirium and its association with cognition. He is the author of several peer-reviewed articles published at various American Journals and a reviewer of internationally renowned journals. Dr. Burhanullah is rated as an Advanced provider by MediFind in the treatment of Alzheimer's Disease. His top areas of expertise are Alzheimer's Disease, Dementia, Vascular Dementia, and Schizophrenia.